Other Event

Other Event

Other Adverse Events are non-serious adverse events that exceed a specific frequency threshold (typically 5% within any study arm). These events are reported to provide comprehensive safety information about all noteworthy adverse occurrences during clinical trials. Each other event is categorized by term, organ system, assessment type, and source vocabulary for standardized reporting.

Other Event path is as follows:

Study -> Results Section -> Adverse Events Module -> Other Event

Study -> Results Section -> Adverse Events Module -> Other Event -> Other Event Stats

Other Event


Ignite Creation Date: 2025-12-24 @ 11:54 AM
Ignite Modification Date: 2025-12-25 @ 11:54 AM
NCT ID: NCT02018861
Term: Sinusitis
Organ System: Infections and infestations
Assessment Type: SYSTEMATIC_ASSESSMENT
Source Vocabulary: MedDRA 23.1
Notes: None
Study: NCT02018861
Study Brief: A Phase 1/2, Open-Label, Dose Escalation, Safety and Tolerability Study of INCB050465 and Itacitinib in Subjects With Previously Treated B-Cell Malignancies (CITADEL-101)
Other Event Stats (If Any):

Other Event Stats

Group ID # Events # Affected # At Risk View
EG000 0 0 1 View
EG001 1 1 3 View
EG002 0 0 3 View
EG003 2 1 34 View
EG004 3 3 27 View
EG005 0 0 4 View
EG006 1 1 8 View
EG007 0 0 3 View
EG008 0 0 4 View
EG009 0 0 1 View
EG010 7 6 88 View